Silent ischaemia and hypertension.

Area of Science:

• Cardiology
• Clinical Medicine
• Pathophysiology

Background:

• Silent ischemia is a recognized clinical entity with established relevance in various patient groups.
• The pathophysiology of silent ischemia involves factors affecting both cardiac supply and demand.
• The reasons for symptomatic versus asymptomatic presentations in patients with ischemia are not fully understood.

Purpose of the Study:

• To explore the pathophysiology of silent ischemia.
• To investigate factors influencing the ischemic pain threshold.
• To examine the prevalence and risk factors for silent ischemia, particularly in hypertensive patients without coronary artery disease.

Main Methods:

• Review of existing studies on silent ischemia prevalence and pathophysiology.
• Investigation of factors influencing cardiac supply and demand in ischemic episodes.
• Consideration of diagnostic challenges like left ventricular hypertrophy and proposed solutions using stringent ST depression criteria.

Main Results:

• Silent ischemia shows a high prevalence across different patient groups.
• Hypertension without coronary artery disease identifies a high-risk population for silent ischemia.
• Reduced coronary reserve is a key factor in the increased prevalence of silent ischemia in hypertensive individuals.

Conclusions:

• Silent ischemia requires further investigation into its underlying mechanisms and patient-specific presentations.
• Diagnostic criteria for ischemia may need refinement, especially in patients with left ventricular hypertrophy.
• Treatment strategies for silent ischemia, similar to angina pectoris, require further prospective research to determine optimal therapeutic goals.